Researchers identify potential new approaches for early detection and treatment of atherosclerosis

Blockage of arterial blood vessels caused by atherosclerosis is largely responsible for heart attacks and strokes, which are the most common causes of death worldwide.

Antibody trials show encouraging results in patients with high-risk forms of two blood cancers

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers – follicular lymphoma and

December 9, 2024

FDA warns of hidden drug ingredients in Dr Ergin’s SugarMD – Pharmaceutical Technology

The drug contains hidden ingredients glyburide and metformin. Credit: Zorica Nastasic via Getty Images. The US Food and Drug Administration (FDA) has issued a warning

November 7, 2023

LabVantage celebrates customer success with record number of software deployments in FY 2024

April 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.